CorMedix (CRMD) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $108.6 million.
- CorMedix's Consolidated Net Income rose 400227.68% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 49500.26%. This contributed to the annual value of -$17.9 million for FY2024, which is 6252.03% up from last year.
- Latest data reveals that CorMedix reported Consolidated Net Income of $108.6 million as of Q3 2025, which was up 400227.68% from $19.8 million recorded in Q2 2025.
- In the past 5 years, CorMedix's Consolidated Net Income registered a high of $108.6 million during Q3 2025, and its lowest value of -$14.5 million during Q1 2024.
- For the 5-year period, CorMedix's Consolidated Net Income averaged around $2.3 million, with its median value being -$7.4 million (2021).
- Per our database at Business Quant, CorMedix's Consolidated Net Income plummeted by 6414.73% in 2022 and then soared by 400227.68% in 2025.
- Quarter analysis of 5 years shows CorMedix's Consolidated Net Income stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then dropped by 18.7% to -$9.7 million in 2023, then skyrocketed by 238.18% to $13.5 million in 2024, then soared by 706.3% to $108.6 million in 2025.
- Its Consolidated Net Income stands at $108.6 million for Q3 2025, versus $19.8 million for Q2 2025 and $20.6 million for Q1 2025.